Navigation Links


Leukemia in Medical News

Genome of Leukemia Patient Reveals Common Mutations

Findings could help scientists understand genetic basis of cancer WEDNESDAY, Aug. 5 (HealthDay News) -- Decoding the genome of a man with acute myeloid leukemia (AML) revealed genetic mutations that may be common among other cancer patients. Scientists at the Washington University S...

Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom

WHITE PLAINS, N.Y., July 30 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) congratulates Janet Davis Rowley, M.D., of University of Chicago, a pioneer in demonstrating that cancer is a genetic disease, for being awarded the 2009 Presidential Medal of Freedom. President Barack ...

Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease

St. Jude scientists identify new genes implicated in childhood acute myeloid leukemia (AML), but analysis underscores the need for more detailed look at the complete AML genome MEMPHIS, Tenn., July 27 /PRNewswire-USNewswire/ -- The most comprehensive analysis yet of the genome o...

Molecule Helps Leukemia Cells Hide From Immune System

Discovery might lead to new strategies to fight the disease, researchers say THURSDAY, July 23 (HealthDay News) -- Leukemia stem cells cleverly cloak themselves to avoid detection by a person's immune system, according to a pair of studies by researchers at Stanford University Medical ...

Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society

MUNDELEIN, Ill., July 23 /PRNewswire/ -- Sysmex today announced its customer appreciation dinner fundraiser for the Illinois Chapter of The Leukemia & Lymphoma Society (LLS) has resulted in a combined company/customer donation of $20,000 for LLS. Monies will be directed toward...

The Leukemia & Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster

WHITE PLAINS, N.Y. and CAMBRIDGE, Mass., July 20 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and FORMA Therapeutics today announced a partnership to accelerate LLS's pipeline of research projects entering late pre-clinical development. The collaboration will beg...

The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense

WASHINGTON, June 18 /PRNewswire-USNewswire/ -- George Dahlman, senior vice president of public policy for The Leukemia & Lymphoma Society (LLS), testified today before the U.S. Senate Subcommittee on Defense Appropriations, calling for funding for a dedicated, stand-alone blood cancer research...

Taking Aim at Relapse of Leukemia in Kids

Researchers say discovery could lead to lifesaving drugs ,,,, WEDNESDAY, June 17 (HealthDay News) -- Scientists have identified molecules that enable tumor cells to invade the nervous system of patients with a blood-borne childhood cancer, a finding that may lead to the development of...

Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)

Oncology Test Further Highlights Broad Market Applicability of GeneXpert System SUNNYVALE, Calif., June 17 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today announced the release of its improved Xpert(R) BCR-ABL Monitor test to be marketed as a CE IVD product under the Euro...

Loyola fellow receives Amgen grant to study treatments for older leukemia patients

MAYWOOD, Il. -- Dr. Aileen Go of Loyola University Health System, who is studying treatment options for older leukemia and lymphoma patients, has won a prestigious Amgen Foundation Fellowship grant. Go, a second-year fellow in hematology/oncology, will work with Dr. Patrick Stiff, director of ...

5 Spanish centers join a study for a new leukemia and lymphoma treatment technique

The Gamida Cell-Teva Joint Venture announced today that five prestigious cord blood transplantations centers in Spain, three in Barcelona and two in Valencia, have joined the ExCell study. Participating clinical sites include, in alphabetical order: Hospital Clnic of Barcelona, Barcelona...

Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO

-- Conference Call Scheduled for Monday June 1 at 1:00 PM ET to Discuss ASCO Data Presentations -- SOUTH SAN FRANCISCO, Calif., May 26 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of ne...

Cole Foundation injects $2.5 million to bolster leukemia research

This press release is available in French . Montreal, May 22, 2009 - Canada has received new support to recruit some of its best minds in pediatric leukemia research, thanks to the Cole Foundation. The family foundation has generously pledged $2.5 million to support up-and-coming, Montre...

Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought

SEATTLE, April 30 /PRNewswire-USNewswire/ -- The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Mee...

Researchers find drug that inhibits acute leukemia cell growth

SAN DIEGO - Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered how to turn off a certain receptor that promotes the growth of leukemia cells. The pre-clinical study was presented today in a platform session at the 22nd annual mee...

Vince Papale and Eagles Fly for Leukemia Tee Up for a Cure at May 4, 2009 Celebrity Golf Classic and Auction

HUNTINGDON VALLEY, Pa., April 20 /PRNewswire/ -- They're young, brave and hopeful, battling the cancers that still claim too many of their lives and leave too many with permanent neurological and other effects. They're the children in our neighborhoods waiting for a cure. Teeing up for a cu...

The Nation's Triathlon to Benefit The Leukemia & Lymphoma Society is Sold Out But There's Still a Way In!

Sign up with LLS's Team in Training WASHINGTON, April 20 /PRNewswire/ -- The Nation's Triathlon(TM) to Benefit The Leukemia & Lymphoma Society (LLS) is sold out, but you can still participate by joining LLS's Team In Training(R) program. The Nation's Tri, the only triathlon dedicate...

New biomarker may predict leukemia aggressiveness

Scientists at the University of California, San Diego and the Moores UCSD Cancer Center have evidence of a potential new biomarker to predict the aggressiveness of an often difficult-to-treat form of leukemia. They found that high levels of a particular enzyme in the blood are an indicator that ch...

Success of Colorful School Supply Collection Inspired by Leukemia Patient Kicks off Second Year

Proceeds from "Kendall Kollection" benefit The Leukemia & Lymphoma Society WHITE PLAINS, N.Y., April 14 /PRNewswire/ -- When Jacqueline Savage McFee, a designer of popular trendy school and office fashion products, got the devastating news that her two-year-old cousin, Kendall Sierens, wa...

Scientists Identify Key Gene That Protects Against Leukemia

Researchers have identified a gene that controls the rapid production and differentiation of the stem cells that produce all blood cell types -- a discovery that could eventually open the door to more streamlined treatments for leukemia and other blood cancers, in which blood cells proliferate ou...

Families of Children Affected by Leukemia Get Boost of Support Thanks to Gift From Chrysler Jeep Superstores

Gift To Be Presented At Telethon Will Help Raise Funds, Awareness For Children's Leukemia Foundation of Michigan Donation Part Of Long History Of Support For CLFM CLARKSTON, Mich., March 17 /PRNewswire/ -- Families of children affected by leukemia will receive an extra boost of support t...

Gap Inc., The Leukemia & Lymphoma Society Encourage Shoppers to Support Cancer-Fighting Programs

Gap Inc. donating portion of spring promotion WHITE PLAINS, N.Y., March 10 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today announced a partnership with Gap Inc. through its Give & Get program, to raise funds for LLS's blood cancer research, patient education and support i...

Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse

The study is supported by The Leukemia & Lymphoma Society(R) PRINCETON, N.J., March 10 /PRNewswire/ -- Celator Pharmaceuticals today announced that the first patient has been treated in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Lip...

World first treatment for leukemia being developed in Australia

Two Australian research groups are undertaking pioneering studies into the causes of leukaemia, potentially leading to patients receiving new drug treatments as early as next year. Led by Dr Andrew Wei and Professor Shaun Jackson from The Australian Centre for Blood Diseases/Alfred Hospital and...

Prescription Copay Assistance for Patients taking Gleevec or Tasigna for Philadelphia chromosome-positive Chronic Myelogenous Leukemia (Ph+ CML)

Novartis Pharmaceuticals Corporation offers a prescription copay assistance program for Ph+ CML (Chronic Myelogenous Leukemia or Chronic Myeloid Leukemia) patients through the My CML Circle Copay Assistance Program ( www.mycmlcircle.com ). East Hanover, NJ (PRWEB) Febru...

Scientists uncover indicator that warns leukemia is progressing to more dangerous form

Scientists at the Moores Cancer Center at the University of California, San Diego, Stanford University School of Medicine and other centers have identified a mechanism by which a chronic form of leukemia can progress into a deadlier stage of the disease. The findings may provide physicians with an...

Signs of Leukemia Show Up Years Before Diagnosis

Study suggests abnormal blood cells hold clues to start of chronic lymphocytic leukemia WEDNESDAY, Feb. 11 (HealthDay News) -- Abnormal blood cells can appear in the blood years before a person is diagnosed with chronic lymphocytic leukemia (CCL), U.S. researchers say. They added ...

New genes involved in acute lymphoblastic leukemia play fundamental role in prognosis of the disease

This release is available in Spanish . The inactivity or "silence" of certain genes plays a fundamental role in the prognosis of acute lymphoblastic leukemia as well as in response to treatment, according to the results of research involving a team made up of specialists from the Universi...

The Leukemia & Lymphoma Society and Women's Running Magazine Join Forces to Launch New All-Women Half Marathon in St. Petersburg

City officials grant permission today for the event to take place November 21-22 WHITE PLAINS, N.Y. and ST. PETERSBURG, Fla., Feb. 5 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Women's Running magazine laud St. Petersburg city officials' announcement today gra...

St. Jude finds more than 100 gene variations linked with response to leukemia treatment

Scientists from St. Jude Children's Research Hospital and the Children's Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for ...

In Kids, Genes May Affect Leukemia Treatment

Finding could help tailor therapy regimen to individuals, experts say TUESDAY, Jan. 27 (HealthDay News) -- Genetic variations appear to affect the way children respond to treatment for lymphoblastic leukemia, researchers report. Although about 80 percent of children suffering from t...

Hard-to-Treat Leukemia Cell Subtype Identified

Discovery suggests new treatments for aggressive form of childhood disease, study says WEDNESDAY, Jan. 14 (HealthDay News) -- Researchers say they may have identified a subtype of T-lymphoblastic leukemia (T-ALL) in children that does not respond to standard intensive chemotherapy. ...

Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society

WHITE PLAINS, N.Y., Jan. 13 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has awarded a $550,000 grant to Anthony Letai, M.D., Ph.D., Department of Medical Oncology at Dana-Farber Cancer Institute in Boston. Millennium: The Takeda Oncology Company of Cambridge, MA provided support to t...

Childhood Leukemia Subtype Resists Treatment

Those with rare gene have disease relapse often within 5 years of apparent remission FRIDAY, Jan. 9 (HealthDay News) -- Researchers say they have identified a rare subtype of a childhood leukemia that does not respond well to treatment. Those with the subtype of acute lymphoblastic ...

Gene Governs Response to Leukemia Chemotherapy

Acute lymphoblastic leukemia is most common pediatric cancer WEDNESDAY, Jan. 7 (HealthDay News) -- A mutation in leukemia cells predicts which children with acute lymphoblastic leukemia are more likely to relapse. The discovery, reported online Jan. 7 in the New England Journal of ...

Gene abnormality found to predict childhood leukemia relapse

Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the...

The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development

WHITE PLAINS, N.Y. and KANSAS CITY, Kan., Jan. 7 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and The University of Kansas Cancer Center have announced a partnership to translate discoveries by LLS-funded researchers into Phase I clinical trials. Currently, The University of K...

Grape Seed Extract Kills Leukemia Cells in Lab

Finding might lead to new treatment for blood cancers, researchers say WEDNESDAY, Dec. 31 (HealthDay News) -- More than three-quarters of laboratory leukemia cells exposed to an extract from grape seeds died within 24 hours, effectively killing themselves while leaving other cells unha...

Stem cells and leukemia battle for marrow microenvironment

Learning how leukemia takes over privileged "niches" within the bone marrow is helping researchers develop treatment strategies that could protect healthy blood-forming stem cells and improve the outcomes of bone marrow transplantation for leukemia and other types of cancer. In a paper in the ...

Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting

Findings confirm advantages of fixed-ratio drug delivery and lay the groundwork for Phase 2 trials already underway in first-line and first-relapse Acute Myeloid Leukemia (AML) settings PRINCETON, N.J., Dec. 9 /PRNewswire/ -- Celator Pharmaceuticals today announced that a Phase 1 dose esc...
Other Tagsplaceplaceplaceplaceplaceplaceendsendsendsdropsdropscountshostsadaptadaptadaptadapt
(Date:11/24/2009)...upus Research Institute (LRI) today named 12 new g...6 million, recognize innovative work across a broa...r their creativity, novelty, and potential to driv...t, and cure the complex disease of systemic lupus....d lupus researchers across the nation and include ...
(Date:11/24/2009)...ger and the American College of Medical Toxicology... the publication of the Journal of Medical Toxico...inning in March 2010. It was previously published... Journal of Medical Toxicology , an international... the science and practice of medical toxicology. ...
(Date:11/24/2009)... release is available in Spanish . , The pr... levels of inflammatory substances in the blood, h... shown by a research project of the University of ...cientist at the School of Pharmacy. , The projec... in relation to the control of body weight and inf...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7New biofactories produce rare healing substances in the endangered Devils claw plant 54597 1New biofactories produce rare healing substances in the endangered Devils claw plant 54597 2New biofactories produce rare healing substances in the endangered Devils claw plant 54597 3Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2
(Date:11/27/2009)...mission vehicles may reduce future disease burden,...althDay News) -- Encouraging city dwellers to walk...h greater public health benefits than increased us... found. , The study compared the projected heal...port scenarios for London, England, and Delhi, Ind...
(Date:11/27/2009)...i-purpose bilingual coloring books designed for ch...ess community to educate - inform parents and chil...sues to Dinosuars to ABC,S and a host of other top...RWEB) November 27, 2009 -- Today’s children ...hem busy any hour of the day, but one of the oldes...
(Date:11/26/2009)... Nov. 27 The diabetes population i...xt 25 years and annual medical spending on the dis...3 billion today, according to a study published in...nal Changing Diabetes ® Program (NCDP), a pr...y a team from the University of Chicago. ,, Acc...
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
Other Contentstradetradetradetradetradetradepatientpatientpatientpatientpatientpatientpatientpatientpatientpatientpersonalizedpersonalizedpersonalizedpersonalizedpersonalizedpersonalizedbagbagbagbagbagpainpainpainpainpainpainpainpainpainphantomtechniciantechniciantechniciantechniciantechnician